-
Despite the safety and efficacy of the Copper T intrauterine device (ParaGard IUD, Barr Pharmaceuticals; Pomona, NY), the levonorgestrel intrauterine system (Mirena IUS, Bayer HealthCare Pharmaceuticals; Wayne, NJ), and the single-rod contraceptive implant (Implanon, Organon; Roseland, NJ), the most popular methods in the United States are oral contraceptives (OCs) and sterilization.
-
Cervical cancer, once one of the most common cancers affecting U.S. women, now ranks 14th in frequency among American women. Thanks to the introduction of the Papanicolaou (Pap) smear, the incidence of invasive cervical cancer has seen a dramatic drop. Between 1955 and 1992, U.S. cervical cancer incidence declined by 74%.
-
Thinking of new ways to reach out to patients? Planned Parenthood Columbia Willamette (PPCW) in Portland, OR, has linked services to the Internet.
-
When it comes to HIV in the United States, young people are disproportionately at risk: An estimated 50% of new HIV infections occur among those under age 25.
-
-
Sinusitis is one of the most common diagnoses in acute care medicine. It accounts for almost 3 million ambulatory care visits annually in the United States.
-
-
Capitalizing on data from a rather homogenous population of breast cancer patients treated with a single chemotherapy regimen (FEC), Jenkins and Freeman found that pretreatment absolute neutrophil and absolute lymphocyte counts, examined together, were highly predictive of risk for all neutropenic events, including febrile neutropenia, dose delays, and overall reduced dose intensity over the six cycle course of treatment.
-
In a population-based retrospective review of first-line treatment of metastatic renal cell carcinoma, sunitinib was shown to double overall survival when compared to interferon alpha.
-
